Nevro Corp (1N7N)

45.8000
+2.2000(+5.05%)
  • Volume:
    0
  • Bid/Ask:
    0.0000/0.0000
  • Day's Range:
    45.8000 - 45.8000
  • Type:Equity
  • Market:Germany
  • ISIN:US64157F1030
  • WKN:A12EPL

1N7N Overview

Prev. Close
43.6
Day's Range
45.8-45.8
Revenue
-
Open
45.8
52 wk Range
38.8-131
EPS
-
Volume
0
Market Cap
1.65B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
548
P/E Ratio
-
Beta
-
1-Year Change
-66.57%
Shares Outstanding
35,260,684
Next Earnings Date
-
What is your sentiment on Nevro Corp?
or
Market is currently closed. Voting is open during market hours.

Nevro Corp News

  • Nevro Posts Q1 Revenue of $87.8M
    • ByInvesting.com-

    Nevro (NVRO) reported Q1 revenue of $87.8 million versus the consensus estimate of $86.18 million.GUIDANCE:Nevro sees Q2 2022 revenue of $103-106 million, versus the consensus of...

Nevro Corp Analysis

Nevro Corp Company Profile

Nevro Corp Company Profile

Nevro Corp. is a global medical device company, which is focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system. SCS is a neuromodulation platform for the treatment of chronic pain, with the Senza Omnia platform, which is in addition to the Senza family of products. The Company’s solution for chronic pain includes 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain based on what it believes to be the best clinical evidence available. The advantages of its 10 kHz Therapy over traditional SCS include demonstrated superior efficacy data for both leg and back pain, paresthesia free pain relief for patients, anatomical lead placement for physicians, and ability to treat a broader group of chronic pain patients.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • whoo
    0
    • Focus: Industrials spike to major resistance, Retail sector clears key trendline, Boeing takes flight, Apple extends triangle breakout, XLI, XRT, BA, AAPL, NVRO https://www.marketwatch.com/story/charting-a-bull-flag-breakout-sp-500-knifes-within-view-of-record-high-3028-2019-09-12?mod=mw_quote_news
      0
      • Nevro price target raised to $205 from $175 at Truist Securities, stock rated buy
        0
        • Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
          0
          • DUMP!! No earnings! not a "value" company!!
            1
            • going down
              1